Rare diseases
Investigational molecules
Locations
Back to Poland1 232 clinical trials in Oświęcim, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis
PolandStudy on the Effects of DHEA and Melatonin on Sleep and Mood in Postmenopausal Women with Sleep Disorders
PolandStudy of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma
PolandStudy on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors
PolandAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
PolandA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
PolandSafety, Tolerability and Immunogenicity of RSV prefusion F protein 847a and 847b Vaccine in Children 5‑17 Years at High Risk of RSV Disease
PolandSafety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents
PolandEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
PolandLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
PolandA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
PolandRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical research in Oświęcim is strongly focused on neurology, with studies addressing migraine, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and multiple system atrophy. These trials are mainly testing new treatment options and exploring ways to slow disease progression, improve symptom control, and support daily functioning.
The overall goal is to identify therapies that may better manage symptoms while also improving long-term neurological outcomes.
Another major area of activity covers cardiovascular diseases and metabolic disorders, including heart failure, arterial hypertension, atrial fibrillation, myocardial infarction, obesity, and type 2 diabetes. The studies are designed to evaluate treatment effectiveness, improve risk reduction, and support better control of blood pressure, heart function, and blood sugar.
These trials reflect a clear interest in preventing complications and improving long-term cardiovascular and metabolic health.
Research in digestive system diseases is active, especially for Crohn’s disease and ulcerative colitis. Trials in this area are evaluating new therapies that aim to reduce inflammation, help patients reach remission, and improve digestive symptoms and quality of life.
This field remains one of the most prominent therapeutic areas in the city’s trial landscape.
Several trials focus on respiratory tract diseases, including asthma, chronic obstructive pulmonary disease, respiratory tract infections, and inflammatory lung disease. The research is centered on testing therapies that may improve breathing, reduce inflammation, and better control flare-ups.
These studies aim to support more effective symptom relief and stronger disease control.
The city also hosts trials in immune system diseases, skin and connective tissue diseases, and allergic conditions. Key areas include psoriasis, chronic spontaneous urticaria, cold-induced urticaria, cutaneous lupus erythematosus, and other inflammatory skin disorders, with research aimed at improving symptom relief and treatment response.
These trials are important for patients whose symptoms remain difficult to control with standard care.
Trials in musculoskeletal diseases and pain conditions include chronic low back pain, post-surgical neuropathic pain, post-herpetic neuralgia, and spasticity-related disorders. The main focus is to assess whether new therapies can reduce pain, ease stiffness, and improve movement and comfort in daily life.
In Oświęcim, this area reflects ongoing efforts to improve quality of life for patients living with persistent pain and mobility limits.
Research related to hormonal diseases and nutritional and metabolic diseases includes type 1 diabetes, type 2 diabetes, obesity, overweight, and mixed dyslipidemia. These studies are largely aimed at improving metabolic control, supporting weight reduction, and lowering long-term health risks.
This area shows a strong interest in therapies that address both disease control and broader cardiometabolic health.
Within neoplasms, studies include breast cancer, non-small cell lung cancer, and metastatic hormone-sensitive prostate cancer. The trials are designed to test new treatment strategies, evaluate safety, and look for better ways to manage advanced or difficult-to-treat cancers.
These oncology studies contribute to the search for more effective and tolerable cancer care.
Some trials focus on broader immune-mediated inflammation and related autoimmune disorders such as Crohn’s disease, ulcerative colitis, and lupus-related conditions. The purpose is to explore treatments that may control immune activity more effectively and reduce disease burden over time.
These studies are relevant for patients needing better options when standard therapies are not enough.
Smaller but notable studies cover conditions such as erosive esophagitis, short bowel syndrome-associated intestinal failure, and post-surgical nutritional challenges. This work aims to improve digestive recovery, symptom relief, and overall nutritional status.
These trials address highly specific needs in patients with limited treatment options.
There is also research in mental disorders and cognitive symptoms, including agitation in dementia and mild cognitive impairment. The studies are intended to evaluate therapies that may improve behavior, thinking, and overall functioning for patients and caregivers alike.
These trials highlight the growing connection between brain health, behavior, and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
